Aegicare

About:

Aegicare is an artificial intelligence platform empowering precision medicine.

Website: https://www.aegicare.com/

Top Investors: DHVC, ASBV, Vinno Capital, Lishen Capital

Description:

Aegicare develops gene intelligence algorithms for patients, medical institutions, scientific research institutions, and pharmaceutical companies. That provides sample management, bioinformatics analysis, a family map, and information retrieval. Aegicar uses genetic intelligence to diagnose rare diseases and develop drugs. Aegicar Aegicar develops gene intelligence algorithms for patients, medical institutions, scientific research institutions, and innovative pharmaceutical companies based on cutting-edge bioinformatics, medical genetics, high-throughput sequencing technology, functional genomics technology, artificial intelligence, and cloud computing technology to solve rare disease-related information mining, translation, interpretation, clinical decision-making assistance, and drug development.

Total Funding Amount:

$7.8M

Headquarters Location:

Palo Alto, California, United States

Founded Date:

2017-01-01

Founders:

Jian Ma, Lv Peitao, Yang Li

Number of Employees:

51-100

Last Funding Date:

2019-06-14

IPO Status:

Private

Industries:

© 2025 bioDAO.ai